REGN

$834.04 -0.20% $-1.70
Aug 21, 2026 04:00 AM

Regeneron is a biotechnology company that discovers, develops, and manufactures innovative medicines for serious diseases.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Aug 23, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Supercharge Your REGN Trading Now

Unlock the full potential of REGN with OHLCX Platform’s cutting-edge automated trading system. Our platform provides precise price action analysis, advanced technical indicators, and powerful quantitative algorithms. Boost your investment success with us and transform your trading experience today!

Unlock Full Potential Now

Frequently Asked Questions

Key products include EYLEA (for eye diseases), Dupixent (for asthma and eczema), and Libtayo (for skin cancer).

You can invest in Regeneron by purchasing shares through a brokerage account or investing in funds that include REGN stock.

Regeneron developed monoclonal antibody treatments for COVID-19, which have been authorized for emergency use.

Regeneron conducts extensive clinical trials to test the safety and efficacy of its drugs before seeking regulatory approval.

Regeneron is committed to sustainability in its operations, focusing on minimizing environmental impact and promoting social responsibility.

Yes, Regeneron is publicly traded on the NASDAQ under the ticker symbol REGN.

Risks include regulatory approvals, competition, patent expirations, and market acceptance of its products.

Regeneron works with healthcare providers and payers to ensure its medications are accessible and affordable.

Regeneron was founded in 1988 and has since become a leader in biotechnology and pharmaceutical innovation.

Regeneron invests heavily in research and development, with a focus on genetic and molecular medicine to treat serious diseases.

Unlock Your REGN Trading Now

Experience the future of trading with OHLCX execution platform. Our advanced system delivers in-depth analysis and insights for REGN, utilizing state-of-the-art technical tools and strategies. Elevate your trading approach instantly and see how we can elevate your trading results!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.